PineStone Asset Management Inc., a registered investment adviser, initiated a new position in Johnson & Johnson (NYSE:JNJ) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 2,067,667 shares of the Healthcare company, valued at approximately $427,903,686 as of the filing date.
Johnson & Johnson's stock currently trades at $219.94 with a market capitalization of $505,783,320,763.
